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Proline stands apart from the other 19 canonical amino acids.Its cyclic side chain uniquely shapes protein structure and
facilitates protein dynamics. As proline’s side chain substantially
restricts its backboneψ angle and removes a backbone hydrogen
bond donor, proline disrupts the regular structures of both
R-helices and β-sheets and can introduce flexibility into these
structures.14 Further, proline’s backbone N-substitution biases
its peptide bonds to the cis conformer, relative to other peptide
bonds. The cistrans isomerization of proline peptide bonds is
well documented to mediate protein folding and mature protein
function.5 Here we examine which of the above properties
contribute to function of the D2 dopamine G protein-coupled
receptor (GPCR) at conserved proline sites within its transmem-
brane R-helices (TMs), using conventional and unnatural amino
acid mutagenesis.
Transmembrane proline residues are a characteristic feature of
GPCRs and are found in five of the D2 receptor’s seven TMs.
These prolines are also highly conserved; three (P2015.50,
P3886.50, and P4237.50) are the most conserved residue of their
respective helix among Class A GPCRs, and the remaining two
(P892.59, P1694.59) are conserved among aminergic GPCRs.
(Superscripts refer to BallesterosWeinstein numbering, in
which the most conserved residue of helix X is denoted X.50).6
A wealth of conventional mutagenesis studies has already estab-
lished that these prolines play some significant functional role in
GPCRs.714 Proline kinks have long been hypothesized to mediate
the helical movements involved in GPCR activation, acting as
pivot points, hinges, and/or swivels to expose a G protein bind-
ing site at the intracellular end of the helical bundle.15,16 A recent
crystal structure of the closely related D3 dopamine receptor
confirms that the prolines investigated here are associated with
helical kinks, especially prominent in TMs 2, 6, and 7 (Figure 1).17
P1694.59 sits only one helical turn from the N-terminus of
TM4, although the pre-proline turn is indeed kinked relative
to the rest of the helix. Interestingly in the D3 and other GPCR
crystal structures, TM5 is only slightly kinked and instead
Figure 1. Two views of the crystal structure of the D3 dopamine
receptor (PDB code 3PBL), highlighting the prolines considered here.15
Numbering is for the corresponding residues in the D2 receptor.
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ABSTRACT: G protein-coupled receptors (GPCRs) contain a
number of conserved proline residues in their transmembrane
helices, and it is generally assumed these play important functional
and/or structural roles. Here we use unnatural amino acid muta-
genesis, employing R-hydroxy acids and proline analogues, to
examine the functional roles of five proline residues in the trans-
membrane helices of the D2 dopamine receptor. The well-known
tendency of proline to disrupt helical structure is important at all
sites, while we find no evidence for a functional role for backbone
amide cistrans isomerization, another feature associated with
proline. At most proline sites, the loss of the backbone NH is
sufficient to explain the role of the proline. However, at one site, P2105.50, a substituent on the backboneN appears to be essential for
proper function. Interestingly, the pattern in functional consequences that we see is mirrored in the pattern of structural distortions
seen in recent GPCR crystal structures.
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possesses a prominent bulge in the helical turn preceding
P2015.50.1722
Proline’s ability to distort helices most obviously comes from
its lack of backbone hydrogen bond donor ability, which frees its
would-be hydrogen bond acceptor, the backbone carbonyl of the
residue i4 from proline (Figure 2). Additionally, the proline
side chain introduces a steric clash with the i4 carbonyl.
The net effect is usually manifested as a kink, which often frees
the carbonyl i3 to proline as well.2,23,24
Since the 19 other canonical amino acids are ill-suited to probe
the unique properties of proline, unnatural amino acid mutagen-
esis is an especially valuable tool to dissect the basis for a given
proline’s functional importance. As structural information on
GPCRs continues to accrue, the subtle and high precision probes
provided by unnatural residues will become increasingly valuable.
Tests of detailed structural environments and specific functional
roles are significantly facilitated by the unnatural amino acid
methodology.
Here we compare the effect of replacing each of 5 TM prolines
of the D2 receptor with unnatural R-hydroxy acids and an N-
methyl amino acid (Figure 2). We also consider cyclic proline
analogues and conventional amino acids that correspond to the
R-hydroxy acids. Unnatural R-hydroxy acids introduce a back-
bone ester that, like the proline peptide bond it replaces, is not a
hydrogen bond donor (Figure 2). N-Me-Ala, effectively proline
lacking its side chain Cγ, shares N-substitution (and thus lack of
hydrogen bond donor ability) with proline but has greater
conformational freedom. Finally, proline analogues that vary
the size of the ring or introduce substituents can probe tolerance
for subtle changes to the proline side chain as well as cistrans
isomerization. Pipecolic acid (Pip) and azetidine-2-carboxylic
acid (Aze), six- and four-membered ring analogues of proline,
respectively, have a greater cis bias relative to proline, whereas
2-methylproline (2-Me-Pro) is substantially more trans-biased.5
Previously, we have characterized three distinct phenotypes
for functionally important proline residues in ligand-gated ion
channels. In the M1 transmembrane helix of both the R subunit
of the muscle-type nicotinic acetylcholine receptor and the
5-HT3A receptor, a conserved proline in the middle of the helix
can be replaced by a range of R-hydroxy acids, giving essentially
wild-type behavior.25,26 In contrast, incorporating any canonical
amino acid other than proline gave a nonfunctional receptor. A
second phenotype was seen in the M2M3 loop of the 5-HT3A
receptor.27 In this system, cistrans isomerization of a proline
peptide bond is critical for receptor gating (see also refs 28 and 29),
as revealed by a series of cyclic proline analogues with varying cis
preferences. Finally, we have characterized an important proline
aromatic interaction in the Cys loop of the muscle-type nicotinic
acetylcholine receptor, in which the hydrophobicity of a Phe side
chain preceding proline is important for receptor function.30
Using the various unnatural amino acids discussed above, we
sought to determine which of these phenotypes is most applic-
able to the transmembrane prolines of the D2 receptor.
’RESULTS AND DISCUSSION
Experimental Approach. We utilized a recently optimized
electrophysiological readout of the D2 receptor that yields
quantitative doseresponse relationships from receptor activa-
tion of coexpressed GIRK1/GIRK4 channels in Xenopus laevis
oocytes and is amenable to unnatural amino acid mutagenesis by
nonsense suppression.31 Here we probe five new sites of the D2
dopamine receptor with an array of unnatural residues, establish-
ing the generality of this protocol for evaluating GPCR function.
All unnatural amino acid and hydroxy acid mutations as well as
the valine mutants noted in Table 1 were generated by nonsense
suppression, whereas all other mutants were expressed conven-
tionally. A wild-type rescue experiment (incorporating Pro by
Figure 2. Hydrogen bonding patterns in an R-helix for (left to right) a
typical amino acid; proline; an N-methyl amino acid; and an R-
hydroxy acid.
Table 1. Conventional Amino Acid, Hydroxy Acid, and
N-Me-Ala Mutationsa
site EC50 (nM) EC50 (nM)
wild-type 39
Pro892.59 Gly 35 N-Me-Ala 46
Ala 65 Aah 140
Valb 53 Vah 47
Leu 110 Lah 140
Pro1694.59 Gly 180 N-Me-Ala 40
Ala 1300 Aah 59
Valb 1100 Vah 76
Leu >2000c Lah 100
Pro2015.50 Gly >2000c N-Me-Ala 17
Ala 600 Aah 180
Val >2000c Vah 330
Leu NDd Lah NDd
Pro3886.50 Gly 67 N-Me-Ala 92
Ala 230 Aah 58
Valb >2000c Vah 190
Leu 1000 Lah 35
Pro4237.50 Gly 61 N-Me-Ala 22
Ala 140 Aah 21
Valb 170 Vah 45
Leu NDd Lah NDd
aReproducibility of the data is discussed in text. Errors for the goodness
of fit to the Hill equation are presented in the Supporting Information.
bConventional mutant generated by nonsense suppression. cAttempts
to measure large values of EC50 are compromised by background res-
ponses to dopamine at concentrations >100 μM. dNo dopamine-
induced current detected for dopamine concentrations up to 1 mM
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nonsense suppression) at each proline site yielded an EC50
within 2-fold of the wild-type value (see Supporting Infor-
mation), validating the ability to perform nonsense suppression
at all residues considered here.
Because of the indirect nature of the assay, interpretation of
EC50 requires some caution. A detailed discussion of this issue
has been presented elsewhere.32 For present purposes, we
consider EC50 values that differ by a factor of greater than 2 to
be distinguishable in this assay.
General Observations.We began our investigation of the D2
receptor’s transmembrane prolines by incorporating R-hydroxy
acids at each site. For the most part, incorporation of an
R-hydroxy residue is not strongly perturbing; all but one of the
hydroxy acid mutants we could characterize gave EC50's within
5-fold that of wild-type (Figure 3, Table 1). In addition, each
conventional amino acid residue is typically much more perturb-
ing than its unnatural R-hydroxy acid analogue. This trend
suggests the importance of lacking a hydrogen bond donor at
these sites. N-Me-Ala provides an alternative way to remove the
backboneNHgroup, and it is also well-tolerated at all sites. Given
the results for R-hydroxy residues and N-Me-Ala, it is not
surprising that various cyclic proline analogues, which are much
more similar to proline, are well-tolerated at all transmembrane
proline sites, yielding EC50's within 5-fold that of wild-type
(Table 2).
Mutations of proline to the conventional amino acids Ala, Val,
and Leu range frommodestly perturbing to dramatically perturb-
ing (EC50 shifts of 3.5-fold to >2000-fold from wild-type), with
the exception of P892.59, discussed below. Generally, Gly is less
perturbing than the other natural amino acids, with the glaring
exception of P2015.50G. These conventional mutants provide
a useful reference to which we can compare the R-hydroxy
mutants.
The P892.59 site, despite >70% conservation among aminergic
receptors, accepts diverse mutations with only modest functional
consequences. All mutations made, including conventional mu-
tations, give wild-type EC50's or relatively small shifts from wild-
type. Evidently this site, which is located in a helix not intimately
involved in ligand binding or conformational changes, does not
require the unique side chain and hydrogen bonding properties
conferred by proline, and we will not consider it further here.
P1694.59, P3886.50, and P4237.50. For the TM4, 6, and 7
proline sites, we observe hydroxy acid mutations (to Aah, Vah, or
Lah; “ah” signifying R-hydroxy) in all cases to be less perturbing
than the corresponding conventional amino acid mutations (to
Ala, Val, or Leu) (Figure 3, Table 1). In fact,most of the hydroxy acid
mutants for these sites (P1694.59Aah, P1694.59Vah, P3886.50Aah,
P3886.50Lah, P4237.50Aah, andP4237.50Vah) haveEC50's that are not
meaningfully different from that of wild-type (i.e., within the margin
of error we can expect from this assay). As hydroxy acids and proline
both lack backbone hydrogen bond donors, this property alone may
account for proline’s functional role at these sites. However, hydroxy
acids do introduce additional perturbations; they weaken the hydro-
gen bond acceptor strength of the preceding residue’s backbone
carbonyl and create an electrostatic repulsion between the intro-
duced main chain oxygen and the i4 carbonyl.
An alternative way to remove the backbone NH of a peptide
bond is with N-Me-Ala, which contains a fragment of the proline
ring and does not significantly perturb the backbone carbonyl. At
the TM4, 6, and 7 proline sites, N-Me-Ala is not largely perturb-
ing, being essentially equivalent to Aah and producing EC50's
within 2.5-fold that of wild-type (Figure 3, Table 1). This result
suggests that the carbonyl mutation associated with R-hydroxy
residues is not a large factor in these helices.
Given the tolerance for R-hydroxy andN-methyl residues, it is
not surprising that the proline analogues Aze and Pip are also well
tolerated in TM4, 6, and 7 (Table 2). As described in previous
work, Aze and Pip show different intrinsic cistrans preferences
than Pro.5 The minimal impact of these mutations indicates that
cistrans isomerization is not an essential component of receptor
Figure 3. Results for incorporating R-hydroxy acids, their amino acid analogues, Gly, and N-Me-Ala. At four sites, indicated by≈, EC50 is too large to
determine accurately. / = no current detected.
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function. While varying ring size does not substantially alter
function, introducing a methyl substituent at proline’s R carbon
(2-Me-Pro) does produce measurable EC50 shifts at the 388
6.50
and 4237.50 sites but not at 1694.59.
Taken together, the mutagenesis results above indicate that
the key function of proline at these sites is to disrupt theR-helix by
removing the key backbone NH. Any strategy that accomplishes
this, including cyclic residues, R-hydroxy residues, or N-methyl
residues, produces receptors with essentially wild-type function.
Interestingly, Gly is less perturbing than the other conven-
tional amino acids at these sites (Figure 3, Table 1). Glycine is
well-known to have an especially low propensity for helical
structures relative to other amino acids (second-lowest only to
proline),33,34 a property believed to stem both from its high
conformational entropy and from its minimal burial of solvent-
accessible surface area in helices.35 The good tolerance of Gly at
these sites suggests a generic functional requirement for a helix
breaker at these sites. Proline appears to accomplish this by lack
of a backbone hydrogen bond donor, but Gly can achieve the
same end by different means. We do note that although the
P4237.50G mutant gave a near-wild-type EC50, it produced signals
that were generally small, suggesting either poor expression or
diminished receptor efficacy, possibilities we cannot differentiate
with our assay.
Because the R-hydroxy residues do not seriously compromise
receptor function at these sites (the way theirR-amino analogues
do), we can use the R-hydroxy data to consider the effects of side
chain variation. The largest perturbations are seen for Lah at
P1694.59 and Vah at P3886.50. This suggests that the 1694.59 site is
sensitive to size, whereas 3886.50 is sensitive to β branching.
Although no P4237.50 mutants produced dramatic EC50 shifts,
cells injected with appropriate mRNA and tRNA for P4237.50L
and P4237.50Lah mutations gave no response in our assay,
suggesting this site is especially sensitive to steric bulk. Support-
ing this notion, the P4237.50 side chain points directly at TM1 in
the D3 receptor crystal structure, while P1694.59 and P3886.50 are
directed more toward the lipid bilayer.17
P2015.50.The 2015.50 site shows a qualitatively distinct pattern
from the other prolines considered here. As before, R-hydroxy
residues are less perturbing than theirR-amino analogues (Figure 3,
Table 1). Unlike the other proline sites, however, no hydroxy
acid mutation to P2015.50 yields a wild-type EC50. P201
5.50Aah
and P2015.50Vah are loss of function by 4- and 8-fold, respectively
(we were unable to characterize the P2015.50Lah mutant).
Interestingly, N-Me-Ala is minimally perturbing, demonstrating
perhaps even gain of function, and the proline analogues Pip and
Aze are wild-type (Table 2). Taken together, these data suggest
that simply deleting the hydrogen bonding ability of the back-
bone NH is not sufficient to produce a maximally functional
receptor. A substituent on the N is also necessary and can be
either a ring (Pro, Pip, Aze) or a methyl (N-Me-Ala).
Also in contrast to the TM4, 6, and 7 sites, Gly is highly
disruptive at 2015.50, more so than Ala (Figure 3, Table 1).
Together with the fact that no hydroxy acid tested gave a wild-
type EC50 at this site, these findings suggest a more specific need
for proline here, not merely a generic requirement for a helix-
breaking residue.
Phenotypes CorrelatewithHelix Distortions. In addition to
sharing a functional phenotype, the TM4, 6, and 7 prolines all
seem to play a similar structural role (Figure 1). In various
structures of GPCRs, TM4, 6, and 7 all display a significant kink
associated with the proline.1721 Movements of helices 6 and 7
are considered to be critical to receptor activation, with the kinks
playing a prominent role.16 Indeed, in a recent crystal structure
thought to represent an active conformation of the β2 adrenergic
receptor, displacement of TM6 is accomplished by a slight
“unwinding” of the helical turn preceding the proline at position
6.50.36 The movement originates at residue 6.46, the would-be
backbone hydrogen bond acceptor to position 6.50, potentially
providing a direct link between proline 6.50's lack of hydrogen
bond donor ability and functionally important helix flexibility.
The 2015.50 site gave a unique functional phenotype, and
indeed it is clear from Figure 1 that the structural perturbation
associated with the TM5 proline is distinct from what is seen in
helices 2, 4, 6, and 7. Instead of a prominent kink, helix 5 has a
bulge. It has been proposed that this bulge is functionally
significant, as residues in the bulge directly contact ligands in
the agonist binding site. Specifically, the side chain of S1975.46,
which is i4 relative to P2015.50 and located at the center of the
bulge, is thought to contribute a hydrogen bond that is important
to agonist binding.37,38 Evidently, the steric effect of proline’s
N-substitution is key to producing this structural bulge, consis-
tent with the functional requirement for N-substitution we found
at this site.
Conclusions. We have probed five conserved proline sites
located in the transmembrane region of theD2 receptor. Transmem-
brane prolines are not uncommon and are frequently considered to
play important functional roles by introducing structural perturba-
tions and/or increased conformational flexibility to the helix.4,15
In all functionally important transmembrane proline sites we
have investigated to date, i.e., the TM4, 5, 6, and 7 prolines in this
study and theM1 transmembrane proline of two different ligand-
gated ion channels, we find that lack of a backbone hydrogen
bond donor is important for function.25,26 A general phenotype
has emerged in which loss of function caused by mutations to
conventional amino acids ismitigated by the correspondingR-hydroxy
acids. In contrast to this transmembraneprolinephenotype,R-hydroxy
residues produced nonfunctional human 5-HT3 receptors when
replacing a proline that appears to undergo cistrans isomerization.27
This proline lies not in an R-helix, but in a loop/turn region, where
cistrans isomerization seems much more plausible.
We do observe variations on the general transmembrane
proline phenotype. Unlike the D2 receptor’s TM4, 6, and 7
prolines, the requirement for lacking a backbone hydrogen bond
donor is absolute at the ion channel M1 proline sites; conven-
tional amino acids, including glycine, produced completely
nonfunctional channels.25,26 The TM5 proline of the D2 receptor
Table 2. EC50 Values (nM) for Proline Analogue Mutations
a
site Pip Aze 2-Me-Pro
Pro892.59 26 26 64
Pro1694.59 19 25 37
Pro2015.50 34 41 160
Pro3886.50 82 47 130
Pro4237.50 80 15 130
aReproducibility of the data is discussed in text. Errors for the goodness
of fit to the Hill equation are presented in the Supporting Information.
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additionally requires N-substitution for fully wild-type function.
Taken together, these studies establish the power of unnatural
amino acid methodology for dissecting out the various conse-
quences of the proline residue's unique structural features.
’METHODS
Molecular Biology. In these experiments, the cDNA for GIRK1
and GIRK4 was in pBSMXT plasmids and for the D2 receptor (human
long form) was in the pGEMhe plasmid. Site-directed mutagenesis was
performed using the Stratagene QuikChange protocol to generate the
appropriate codon. For unnatural amino acid mutants and conventional
mutants generated by nonsense suppression, the site of interest was
mutated to the TAG stop codon. Plasmids were linearized with the
appropriate restriction enzymes (the GIRK plasmids with SalI and the
D2 receptor with NheI or SbfI). Receptor mRNA was prepared by in
vitro runoff transcription using the Ambion T7mMessage mMachine kit
and GIRK1 and GIRK4 mRNA was prepared with the T3 kit.
Hydroxy or amino acids, all commercially available, were appended to
the dinucleotide dCA and enzymatically ligated to truncated 74mer
THG73 tRNA as previously described.39,40 The 74mer tRNA was
prepared using the Ambion T7MEGAshortscript kit by transcription
from a DNA oligonucleotide template with its 50 terminal two nucleo-
tides bearing methoxy groups at the ribose C20 position, as described in
the literature to enhance RNA transcript homogeneity.41 Crude tRNA-
amino acid or tRNA-hydroxy acid product was used without desalting,
and the product was confirmed by matrix-assisted laser desorption
ionization time-of-flight mass spectrometry on a 3-hydroxypicolinic acid
matrix. Deprotection of the NVOC group on the tRNA-amino acids or
NB group on tRNA-Aah was carried out by 5-min photolysis on a 1 kW
xenon lamp with WG-335 and UG-11 filters immediately prior to
injection. tRNA-Vah and -Lah were unprotected and were injected
directly.
Oocyte Preparation and RNA Injection. Stage VVI oocytes
of Xenopus laevis were harvested and injected with RNAs as described
previously.39 For nonsense suppression experiments, each cell was
injected with 15 ng each of GIRK1 and GIRK4 mRNA approximately
64 h before recording and then 430 ng of receptor mRNA and
approximately 2560 ng of appropriate tRNA approximately 48 h before
recording.Mutants yielding small responses required a second injection of
receptor mRNA and appropriate tRNA 24 h before recording.
For wild-type experiments, each cell received a single injection of
0.16 ng of receptor mRNA and 10 ng each of GIRK1 and GIRK4mRNA
approximately 48 h before recording. Conventional amino acid mutants
(except those generated by nonsense suppression) were prepared
identically, except 1 ng of receptor mRNAwas required. Small responses
were obtained for P4237.50G, which required 10 ng of receptor mRNA.
Injection volumes for each injection session were 2575 nL per cell.
As a negative control for suppression experiments at each site,
unacylated full length tRNA was co-injected with mRNA in the same
manner as charged tRNA. These experiments yielded negligible re-
sponses for all sites. Wild-type recovery conditions (injecting tRNA-Pro
and appropriate mRNA) were injected alongside mutant nonsense
suppression conditions to control for data variability.
Electrophysiology. Oocyte recordings were made in two-elec-
trode voltage clamp mode using the OpusXpress 6000A (Axon In-
struments). Recording buffers were ND96 (96 mM NaCl, 2 mM KCl,
1 mMMgCl2, 5 mMHEPES, 1.8 mMCaCl2, pH 7.5) and high K
+ ringer
(96 mM NaCl, 24 mM KCl, 1 mM MgCl2, 5 mM HEPES, 1.8 mM
CaCl2, pH 7.5). Solution flow rates were 2 mL min
1 and drug
application flow rates were 2.5 mL min1. Initial holding potential
was 60 mV. Data were sampled at 125 Hz and filtered at 50 Hz. Cells
were subjected to a ND96 pre-wash for 10 s, a high K+ application for
50 s to establish basal currents, and dopamine application in high K+
ringer for 25 s, followed by high K+ and ND96 washings for 45 and 90 s
in duration, respectively. Dopamine-induced currents were measured
over the basal K+ current as described previously.31 Dopamine (Sigma-
Aldrich) solutions in high K+ ringer were prepared immediately before
recording by dilutions from a 1 M stock in ddi water. Doseresponse
data were obtained for a minimum of eight concentrations of dopa-
mine, for a minimum of two cell batches, and for a minimum of 8 cells
total. Doseresponse relations were fitted to the Hill equation, Inorm =
1/(1 + (EC50/A))
nH, where Inorm is the normalized current peak at
[dopamine] = A, EC50 is the concentration of agonist that elicits a half-
maximum response, and nH is the Hill coefficient. EC50 values were
obtained by averaging the Inorm values for each cell at a given dose and
fitting those averaged Inorm data to the Hill equation.
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